DOT1L Inhibitor Pinometostat (EPZ5676) – New Targeted Therapy in Leukemia
The Pinometostat (EPZ5676) DOT1L Inhibitor is a novel sub-class of targeted epigenetic therapy that has transformed the concept of leukemia treatment. This compound is more specific and perhaps less toxic …









